Sanofi pharmaceuticals

Sanofi is a leading global healthcare company with a rich history rooted in the French pharmaceutical industry. The brand we recognize today is the result of several significant mergers, including the 2004 combination of Sanofi-Synthélabo and Aventis. While its headquarters and origins are firmly established in France, the company has grown into a massive multinational enterprise with a presence in over 100 countries.

Manufacturing for Sanofi products is distributed globally, with major production facilities located in Europe, North America, and emerging markets. This extensive network ensures that their wide range of prescription medicines, vaccines, and consumer healthcare products are accessible to patients and consumers worldwide. The company is particularly well-known for its work in immunology, oncology, and rare diseases.

As of the current landscape moving into 2026, Sanofi remains an independent public company listed on the Euronext Paris and the New York Stock Exchange. It operates with a focus on innovation and digital transformation in the healthcare sector, maintaining its status as one of the world's largest pharmaceutical companies by revenue. Its ownership is diversified among institutional and retail investors globally.